Updates and new perspectives in nonmelanoma skin cancer therapy: highlights from ‘Immunotherapy Bridge’-Reference-Cited by-同舟云学术

Updates and new perspectives in nonmelanoma skin cancer therapy: highlights from ‘Immunotherapy Bridge’

Published:2020-02 Issue:3 Volume:12 Page:167-174
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Ascierto Paolo Antonio¹,Garbe Claus²

Affiliation:

1. Unit Melanoma, Cancer Immunotherapy & Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione ‘G Pascale,’ Napoli, Italy

2. Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany

Abstract

Over the last few years, extensive research has improved our understanding of tumor immunology and has enabled the development of novel treatments. The state of the art of immunotherapy in various types of malignancies was exhaustively discussed in the ‘Immunotherapy Bridge’ meeting, which was held in Naples on 4–5 December 2019. Highlights related to the immunological treatment of nonmelanoma skin cancer are the content of this article.

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt-2020-0042

Reference27 articles.

1. Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology

2. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline

3. Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?

4. Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358.

5. Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing;Chemical Biology & Drug Design;2023-12-15

2. Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-05-15

3. Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers;Cancers;2022-06-10

4. Identification of potential inhibitors of cutaneous Melanoma and Non-Melanoma skin cancer cells through in-vitro and in-silico screening of a small library of Phenolic compounds;2022-03-02

5. Identification of Potential Inhibitors of Cutaneous Melanoma and Non-Melanoma Skin Cancer Cells Through In-Vitro and In-Silico Screening of a Small Library of Phenolic Compounds;SSRN Electronic Journal;2022